PPRC1 and neoplasm: Gidron, in Mouton et al. (2012), De Couck et al. (2013), and Gidron et al. (2014), analyzed data of PrC, CRC, and NSCLC patients with different cancer stages and described significantly higher tumor marker levels in patients with lower HRV.